AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers continue their spree of deals of promising biotech companies.
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers continue their spree of deals of promising biotech companies.
Istanbul football club Fenerbahce Futbol AS is considering whether to withdraw from the country’s top league after rival fans attacked its players on the pitch, in the latest violent incident to tarnish the Turkish sport’s image.
The new boss of Unilever Plc wants to reverse years of lackluster performance with an ambitious plan to separate the conglomerate’s ice cream arm and remove layers of middle management.
Swiss regulators should re-examine the capital requirements placed on UBS Group AG in the light of its increased size following the takeover of Credit Suisse, the Swiss National Bank said.
Ant Group Co. pushed forward a restructuring of its business and plans to set up independent boards for its international, database and digital operations, following broader overhaul plans, according to a memo seen by Bloomberg.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}